KATY, TX / ACCESS Newswire / July 13, 2026 / Hormones act as invisible signaling messengers regulating nearly all biological activities, playing irreplaceable roles in inflammation, reproductive development, tumor microenvironment research, neuroscience and other core life science fields. However, small-molecule hormones face inherent detection bottlenecks: highly similar chemical structures, lack of dual binding epitopes required for conventional immunoassays, ultra-low concentrations in complex biological matrices, and severe background interference. Long-standing pain points including insufficient sensitivity, poor specificity and cumbersome operation have blocked researchers from obtaining authentic experimental data from precious samples.
Commercially available clinical hormone ELISA kits are mainly optimized for simple human body fluids such as serum and plasma, failing to meet research demands for multi-species cell culture supernatants, tissue homogenates, saliva and other complex specimens. To address this industry-wide challenge, Cloud-Clone has launched a full portfolio of high-sensitivity ELISA kits for small-molecule hormone quantification. The standardized detection tools enable researchers to systematically dissect hormone functions in physiological and pathological processes and accelerate translational research in biomedicine.
